NCT01717599View on ClinicalTrials.gov

Intramuscular Diclofenac in the Prevention of Post-ERCP Pancreatitis

NACompletedINTERVENTIONAL
Enrollment

343

Participants

Timeline

Start Date

August 29, 2012

Primary Completion Date

August 28, 2013

Study Completion Date

August 28, 2013

Conditions
Post ERCP Pancreatitis
Interventions
DRUG

Diclofenac

Diclofenac 90mg, 2ml/A, IM(intramuscular) injection immediately after procedure of ERCP

DRUG

normal saline

normal saline 2ml/A, IM(intramuscular) injection immediately after procedure of ERCP

Trial Locations (1)

120-752

Division of Gastroenterology, Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT01717599 - Intramuscular Diclofenac in the Prevention of Post-ERCP Pancreatitis | Biotech Hunter | Biotech Hunter